Shanghai Institute of Materia Medica, Chinese Academy of Sciences
CN | CAS  
 
  Home | Links | Site map
 
Home About Us News Organization Research Faculty Publication Education&Trainning Contact
Upcoming Events
2019 Queenstown Molecular Biology Meetings in Shanghai
 
2019 Queenstown Molecular Biology Meetings in Shanghai
 
more  
 
  Headline more  
Pynegabine, a First Class Anti-epileptic Drug Targeting KCNQ Potassium Channel Approved for Clinical Study
Epilepsy is one of the most common and serious neurological disorders worldwide , affecting approximately 10 million people in China . Due to the fact that about one third of patients are drug-resistant epilepsy .The Strategic Pilot Project in Science and Technology of CAS , Shanghai Municipal Science and Technology Commission , and the self-deployment project of the Institutes of Drug Discovery and Development of CAS .
more
About Us News Research Faculty Education&Trainning Organization Contact
Brief Introduction
History
Address from the Director
Directors
Administration
Research
Events
Int'l cooperation
Target
Discovery
Development
Translation
Academician
PI
Graduate Students
Post Graduate Students